Ypsomed Holding AG
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 --
業務概覽 Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
公司地址 Brunnmattstrasse 6, Burgdorf, CHE, 3401
電話號碼 +41 344244111
傳真號碼 +41 344244122
公司網頁 https://www.ypsomed.com
員工數量 2753
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Simon Michel Director and Chief Executive Officer -- 21/05/2025
 
董事會成員
董事會 職務 更新日期
Mr. Paul Fonteyne, M.S. Vice Chairman of the Board 21/05/2025
Dr. Martin Munchbach, PhD Director 21/05/2025
Ms. Betul Susamis Unaran Director 21/05/2025
Mr. Gilbert Achermann Chairman of the Board 21/05/2025
Mr. Simon Michel Director and Chief Executive Officer 21/05/2025
 
所屬ETF (更新日期: 07/03/2026 04:11)
代號 名稱 佔比% ▼ 持有日期
AVDSAvantis International Small Cp Eq ETF0.002%28/02/2026
TMEDT. Rowe Price Health Care ETF0.001%28/02/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.0004%27/02/2026
GTPEGoldman Sachs MSCI Wld Priv Eq RtTrkrETF0.0001%27/02/2026
BCILBancreek International Large Cap ETF<0.000001%01/10/2025
HSCZiShares Currency Hdgd MSCI EAFE SmCp ETF<0.000001%27/02/2026
TCAFT. Rowe Price Capital Apprec Eq ETF<0.000001%12/02/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.